236 related articles for article (PubMed ID: 12022349)
21. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women.
Fernández M; Calvo-Alén J; Alarcón GS; Roseman JM; Bastian HM; Fessler BJ; McGwin G; Vilá LM; Sanchez ML; Reveille JD
Arthritis Rheum; 2005 Jun; 52(6):1655-64. PubMed ID: 15934092
[TBL] [Abstract][Full Text] [Related]
22. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
[TBL] [Abstract][Full Text] [Related]
23. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
Tomietto P; Annese V; D'agostini S; Venturini P; La Torre G; De Vita S; Ferraccioli GF
Arthritis Rheum; 2007 Dec; 57(8):1461-72. PubMed ID: 18050188
[TBL] [Abstract][Full Text] [Related]
24. Cigarette smoking and cutaneous damage in systemic lupus erythematosus.
Turchin I; Bernatsky S; Clarke AE; St-Pierre Y; Pineau CA
J Rheumatol; 2009 Dec; 36(12):2691-3. PubMed ID: 19884279
[TBL] [Abstract][Full Text] [Related]
25. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
[TBL] [Abstract][Full Text] [Related]
26. SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study.
Laustrup H; Voss A; Green A; Junker P
Lupus; 2010 Mar; 19(3):239-46. PubMed ID: 19946037
[TBL] [Abstract][Full Text] [Related]
27. Associates of health status in patients with systemic lupus erythematosus.
Sutcliffe N; Clarke AE; Levinton C; Frost C; Gordon C; Isenberg DA
J Rheumatol; 1999 Nov; 26(11):2352-6. PubMed ID: 10555890
[TBL] [Abstract][Full Text] [Related]
28. Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years.
Gilboe IM; Kvien TK; Husby G
J Rheumatol; 2001 Feb; 28(2):266-74. PubMed ID: 11246660
[TBL] [Abstract][Full Text] [Related]
29. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.
Neville C; Clarke AE; Joseph L; Belisle P; Ferland D; Fortin PR
J Rheumatol; 2000 Mar; 27(3):675-9. PubMed ID: 10743807
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of patients with late onset systemic lupus erythematosus in Turkey.
Sayarlioglu M; Cefle A; Kamali S; Gul A; Inanc M; Ocal L; Aral O; Konice M
Int J Clin Pract; 2005 Feb; 59(2):183-7. PubMed ID: 15854194
[TBL] [Abstract][Full Text] [Related]
31. Participatory patient-physician communication and morbidity in patients with systemic lupus erythematosus.
Ward MM; Sundaramurthy S; Lotstein D; Bush TM; Neuwelt CM; Street RL
Arthritis Rheum; 2003 Dec; 49(6):810-8. PubMed ID: 14673968
[TBL] [Abstract][Full Text] [Related]
32. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
Hao JH; Ye DQ; Zhang GQ; Liu HH; Dai H; Huang F; Pan FM; Su H; Dong MX; Chen H; Wang Q; Zhang XJ
Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
[TBL] [Abstract][Full Text] [Related]
33. Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvement.
Brunner HI; Feldman BM; Urowitz MB; Gladman DD
J Rheumatol; 2003 Feb; 30(2):292-7. PubMed ID: 12563683
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study.
Stoll T; Sutcliffe N; Mach J; Klaghofer R; Isenberg DA
Rheumatology (Oxford); 2004 Aug; 43(8):1039-44. PubMed ID: 15161983
[TBL] [Abstract][Full Text] [Related]
35. Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus.
Johansson M; Arlestig L; Möller B; Rantapää-Dahlqvist S
Arthritis Rheum; 2005 Jun; 52(6):1665-9. PubMed ID: 15934088
[TBL] [Abstract][Full Text] [Related]
36. Effect of severe neuropsychiatric manifestations on short-term damage in systemic lupus erythematosus.
Fragoso-Loyo HE; Sánchez-Guerrero J
J Rheumatol; 2007 Jan; 34(1):76-80. PubMed ID: 17143970
[TBL] [Abstract][Full Text] [Related]
37. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.
Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD;
Arthritis Rheum; 2006 Oct; 55(5):799-806. PubMed ID: 17013840
[TBL] [Abstract][Full Text] [Related]
38. Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids.
Lee C; Almagor O; Dunlop DD; Manzi S; Spies S; Chadha AB; Ramsey-Goldman R
Rheumatology (Oxford); 2006 Jan; 45(1):53-60. PubMed ID: 16278288
[TBL] [Abstract][Full Text] [Related]
39. Impaired memory and learning abilities in patients with systemic lupus erythematosus as measured by the Rey Auditory Verbal Learning Test.
Paran D; Litinsky I; Shapira-Lichter I; Navon S; Hendler T; Caspi D; Vakil E
Ann Rheum Dis; 2009 Jun; 68(6):812-6. PubMed ID: 18593761
[TBL] [Abstract][Full Text] [Related]
40. Summarizing disease features over time: II. Variability measures of SLEDAI-2K.
Ibañez D; Gladman D; Urowitz M
J Rheumatol; 2007 Feb; 34(2):336-40. PubMed ID: 17183620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
